ClinicalTrials.gg
RecruitingNCT06738888Updated Oct 8, 2026

Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy

An observational study in Thyroid Cancer, Thyroid Diseases and Thyroid Nodule, sponsored by Shanghai 6th People's Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-10-08.

Primary conditionThyroid NoduleRegistry: Thyroid NeoplasmsReclassifiedWhy we changed it
Registry
Thyroid Neoplasms — the first condition term the registry derived for this study.
ClinicalTrials.gg
Thyroid Nodule
Why
  1. The study's listed conditions name Thyroid Nodule, a narrower term within Thyroid Neoplasms.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Shanghai 6th People's Hospital · Observational

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Updated Oct 8, 2026Interventions changedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Sex
All
01

Study summary

The investigators have previously proposed a prediction model for difficult transoral and submental thyroidectomy through a retrospective study. In order to better promote transoral and submental endoscopic approach for thyroid surgery and to set up an appropriate training course, the investigators aim to refine the procedure through a prospective study. As a procedure refinement, a modified strap-muscle dissection technique will be introduced during transoral and submental endoscopic thyroidectomy.

Read the detailed description

This study is a prospectively registered cohort study evaluating postoperative neck functional recovery after TOaST. As a procedure refinement, a modified strap-muscle dissection technique will be introduced during transoral and submental endoscopic thyroidectomy. In the modified approach, the midline separation of the superficial sternohyoid muscle layer will be limited to the upper central neck, approximately to the level of the thyroid cartilage. The deeper sternothyroid muscle layer will be adequately dissected inferiorly as required to maintain sufficient surgical working space. Appropriate lateral retraction of the strap muscles will be used to achieve adequate exposure of the thyroid gland without extending the superficial midline dissection. This refinement is intended to reduce unnecessary disruption of the superficial anterior neck musculature and soft tissues while maintaining satisfactory operative exposure.

Surgical feasibility and safety will be assessed using operative time, intraoperative blood loss, drainage volume, number of central lymph nodes retrieved, recurrent laryngeal nerve events, parathyroid-related outcomes, postoperative complications, and the rate of technical conversion.

02

Conditions studied

  • Thyroid Cancer
  • Thyroid Diseases
  • Thyroid Nodule

Browse trials for

Keywords

  • Endoscopic thyroidectomy
  • Transoral and submental approach
  • Prediction model
03

In context

Thyroid Nodule Reclassified

207 studies on the registry are indexed under Thyroid Nodule; 64 are open to participants now.

This study's planned enrollment of 300 is above the median of 161 across 82 observational studies indexed under Thyroid Nodule.

Browse Thyroid Nodule studies →

Lead sponsor

Shanghai 6th People's Hospital is the lead sponsor of 70 studies on the registry; 41 are open to participants now.

Compared within Thyroid Nodule, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Thyroid Neoplasms. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with FNA proven differentiated thyroid cancer, were willing to undergo thyroidectomy and central lymph node dissection via transoral and submental approach. Patients were well informed about the transoral and submental approach and were aware of the potential benefits and risks. Patient consented for us to use perioperative data.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
  • Clinical diagnosis of benign thyroid nodule with a maximum diameter not exceeding 6 cm
  • Absence of suspicious lateral lymph nodes or distant

Exclusion criteria

Exclusion Criteria:

  • Participants with fusion or fixation of lymph nodes in the neck
  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
  • Participants with preoperative examination suggestive of extrathyroidal invasion
  • Participants with a significantly restricted neck and/or jaw
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Conventional TOaST

    In this group, the midline separation of the strap muscles, including the superficial sternohyoid layer, was extended inferiorly toward the suprasternal notch to obtain operative exposure

  • Modified Strap-Muscle Dissection TOaST

    In this group, midline separation of the superficial sternohyoid muscle layer is limited to the upper central neck, approximately to the level of the thyroid cartilage, while adequate dissection of the deeper sternothyroid muscle layer is maintained as required for operative exposure. Lateral retraction of the strap muscles is used to provide sufficient visualization and working space without extending the superficial midline separation to the suprasternal notch.

    Procedure: Modified Strap-Muscle Dissection Technique

Interventions

  • ProcedureModified Strap-Muscle Dissection Technique

    A refined endoscopic thyroidectomy technique characterized by limited midline separation of the superficial sternohyoid muscle layer, with preservation of adequate deep-layer sternothyroid dissection and lateral strap-muscle retraction to maintain surgical exposure.

06

What researchers measure

Primary outcomes

  1. Postoperative neck functional recovery at 1 month

    Postoperative neck functional recovery will be assessed 1 month after surgery using a standardized neck function assessment, including neck discomfort, anterior neck tightness, swallowing-related traction discomfort, and neck range of motion. Higher impairment scores indicate worse neck functional recovery.

    Time frame: 1 month after surgery

  2. Anterior neck tightness score

    Anterior neck tightness will be assessed using a patient-reported visual analog scale or numerical rating scale. Higher scores indicate more severe tightness.

    Time frame: Postoperative 1 week, 1 month, and 3 months

  3. Swallowing-related traction discomfort

    Swallowing-related traction discomfort will be assessed using a patient-reported visual analog scale or numerical rating scale. Higher scores indicate more severe discomfort.

    Time frame: Postoperative 1 week, 1 month, and 3 months

Secondary outcomes

  1. hospitalization

    days of hospitalization

    Time frame: Length of stay from hospitalisation to discharge

  2. degree of pain

    pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain

    Time frame: approximately 4 hours after surgery and on postoperative day 1

  3. Number of participants with recurrent laryngeal nerve injury

    Impaired vocal cord mobility confirmed by postoperative laryngoscopy

    Time frame: Through study completion, an average of 1 year

  4. Number of participants with hypoparathyroidism

    A postoperative parathyroid hormone level of less than 10 pg/ml

    Time frame: Through study completion, an average of 1 year

  5. Operative time

    Operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet

    Time frame: Immediately at the end of the surgery

  6. Central compartment lymph node yield

    For participants undergoing central compartment lymph node dissection, the number of retrieved central compartment lymph nodes will be recorded and compared between groups.

    Time frame: At the time of pathological assessment after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data are available on request due to privacy or other restrictions. The data that support the findings of this study are available on request from Ling Zhan. The data are not publicly available due to them containing information that could compromise research participant privacy.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Dec 2027, 43 months after the start.

Of 38 observational studies under Thyroid Nodule, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 32. This study's planned 43 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2024
First posted
Dec 18, 2024
StartActual
May 1, 2024
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Interventions
Added Procedure: Modified Strap-Muscle Dissection Technique; removed Procedure: Modified TOaST with caudal linea alba preservation. Arms added: Conventional TOaST·Modified Strap-Muscle Dissection TOaST; arms removed: Conventional TOaST with bilateral strap muscle suspension·Modified TOaST with caudal linea alba preservation
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    Interventions Added Procedure: Modified Strap-Muscle Dissection Technique; removed Procedure: Modified TOaST with caudal linea alba preservation. Arms added: Conventional TOaST·Modified Strap-Muscle Dissection TOaST; arms removed: Conventional TOaST with bilateral strap muscle suspension·Modified TOaST with caudal linea alba preservation
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06738888
Lead sponsor
Shanghai 6th People's Hospital
Responsible party
Ling Zhan (Principal Investigator, Shanghai 6th People's Hospital) — Principal investigator
First posted
Dec 18, 2024
Start date
May 1, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 8, 2026

Study contacts

Ling Zhan, Doctor
Contact
rebecca0428zhan@163.com
08615821120972
Ling Zhan, Doctor
principal investigator · Shanghai 6th People's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion